Molbio Diagnostics.
Company
- Reports this week
- 0
- Active events
- 0
- Connections
- 21
What's happening
Earlier this month
-
The World Health Organization endorsed new TB diagnostics developed by Molbio Diagnostics.Some support2 reports
-
Molbio Diagnostics' share price dropped 2% despite profit growth, while the company also completed a manufacturing capacity expansion program.Some support1 report
-
Both Molbio Diagnostics and Tempsens showed strong IPO performance on August 1, 2026.Some support1 report
One to three months ago
No events began in the chosen period. Widen it, or reset.
Around Molbio Diagnostics this week
News at the entities that move Molbio Diagnostics most-
Goldman Sachs TransactionalGoldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Moves Molbio Diagnostics
-
International Finance Corporation TransactionalThe French Development Agency (AFD) is providing funding to the International Finance Corporation (IFC) for operations in South Africa.Moves Molbio Diagnostics
-
World Health Organization StructuralThe UAE is providing support to ongoing efforts by the World Health Organization to contain the Ebola outbreak in Africa.Moves Molbio Diagnostics
-
Bengaluru StructuralAn AI-led trading platform is serving Indian users, operating out of Bengaluru.Moves Molbio Diagnostics
-
Motilal Oswal Mentioned togetherMotilal Oswal initiated buy coverage on Aster DM Healthcare, noting the company operates a pan-India hospital platform.Moves Molbio Diagnostics
-
Southeast Asia Shared contextHulls moved cargo between China and Southeast Asia.Moves Molbio Diagnostics
Connections
The 12 strongest of 21, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Goldman Sachs Transactional
Goldman Sachs invested in Molbio Diagnostics during its Initial Public Offering.
-
International Finance Corporation Transactional
IFC invested in Molbio Diagnostics during its Initial Public Offering.
-
Tempsens Mentioned together
Both companies were noted for exhibiting strong performance during their IPOs.
-
Africa Shared context
Molbio Diagnostics operates within the geographical and market context of the African continent.
-
World Health Organization Structural
The World Health Organization formally endorsed TB diagnostics produced by Molbio Diagnostics.
-
Bengaluru Structural
Molbio Diagnostics is establishing an R&D facility within the geographical boundaries of Bengaluru.
-
Motilal Oswal Mentioned together
Molbio Diagnostics is co-mentioned with Motilal Oswal in articles discussing its IPO launch.
-
Motilal Oswal Group Mentioned together
Co-mentioned in the context of fund management activities of Motilal Oswal Group.
Show all 12 connections
-
Goa Shared context
Molbio Diagnostics is located in the state of Goa.
-
Southeast Asia Shared context
Molbio Diagnostics is operating within the geographical context of Southeast Asia.
-
Latin America Shared context
Molbio Diagnostics operates within the regulatory context of Latin America.
-
GMP Mentioned together
Evidence is insufficient to establish a relationship between Molbio Diagnostics and GMP; only GMP's IPO interest was noted.
History
Events by the month they beganSeptember 2026
2 eventsAugust 2026
3 events- Both Molbio Diagnostics and Tempsens showed strong IPO performance on August 1, 2026.
- Goldman Sachs, the International Finance Corporation, and Motilal Oswal Group are involved in the Initial Public Offering of Molbio Diagnostics.
- Molbio Diagnostics launched its IPO on August 5, 2026, alongside the Dhoot Transmission issue.